1st Quarter - Report

ALSTON & BIRD LLP for NOVARTIS CORPORATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues related to drug coverage and reimbursement.

Foreign entity interest: To the extent that Novartis Corporation derives any benefit from legislative or executive action, so, too, does its parent corporation, Novartis AG.

LobbyistCovered position, as disclosed
JENNIFER L BUTLER —
ROBERT J DOLE New —
PETER M KAZON —
RUDY MISSMAR —
COLIN ROSKEY —

Contacted: Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA)

Health Issues HCR

Issues related to drug coverage and reimbursement.

Foreign entity interest: To the extent that Novartis Corporation derives any benefit from legislative or executive action, so, too, does its parent corporation, Novartis AG.

LobbyistCovered position, as disclosed
JENNIFER L BUTLER —
PETER M KAZON —
RUDY MISSMAR —
COLIN ROSKEY —

Contacted: Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA)

Medicare/Medicaid MMM

Issues related to drug coverage and reimbursement.

Foreign entity interest: To the extent that Novartis Corporation derives any benefit from legislative or executive action, so, too, does its parent corporation, Novartis AG.

LobbyistCovered position, as disclosed
JENNIFER L BUTLER —
PETER M KAZON —
RUDY MISSMAR —
COLIN ROSKEY —

Contacted: Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.